Medical implants and methods of making medical implants
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-002/00
A61K-031/727
출원번호
US-0648106
(2009-12-28)
등록번호
US-8834913
(2014-09-16)
발명자
/ 주소
Shaw, Wendy J.
Yonker, Clement R.
Fulton, John L.
Tarasevich, Barbara J.
McClain, James B.
Taylor, Doug
출원인 / 주소
Battelle Memorial Institute
대리인 / 주소
Wilson, Sonsini, Goodrich & Rosati
인용정보
피인용 횟수 :
17인용 특허 :
160
초록▼
A medical implant device having a substrate with an oxidized surface and a silane derivative coating covalently bonded to the oxidized surface. A bioactive agent is covalently bonded to the silane derivative coating. An implantable stent device including a stent core having an oxidized surface with
A medical implant device having a substrate with an oxidized surface and a silane derivative coating covalently bonded to the oxidized surface. A bioactive agent is covalently bonded to the silane derivative coating. An implantable stent device including a stent core having an oxidized surface with a layer of silane derivative covalently bonded thereto. A spacer layer comprising polyethylene glycol (PEG) is covalently bonded to the layer of silane derivative and a protein is covalently bonded to the PEG. A method of making a medical implant device including providing a substrate having a surface, oxidizing the surface and reacting with derivitized silane to form a silane coating covalently bonded to the surface. A bioactive agent is then covalently bonded to the silane coating. In particular instances, an additional coating of bio-absorbable polymer and/or pharmaceutical agent is deposited over the bioactive agent.
대표청구항▼
1. A medical implant device comprising: a device substrate having a surface;a silane derivative coating comprising a terminal amine, wherein the silane derivative coating is covalently bonded to the surface;a bioactive agent; anda hetero-bifunctional polyethylene glycol spacer comprising a carboxyl
1. A medical implant device comprising: a device substrate having a surface;a silane derivative coating comprising a terminal amine, wherein the silane derivative coating is covalently bonded to the surface;a bioactive agent; anda hetero-bifunctional polyethylene glycol spacer comprising a carboxyl group and an amine group;wherein the spacer is between the silane derivative coating and the bioactive agent, the carboxyl group of the polyethylene glycol spacer being covalently bonded to the terminal amine of the silane derivative coating through a peptide bond and the amine group of the polyethylene glycol spacer being covalently bonded to the bioactive agent through a peptide bond; wherein the silane derivative coating is first bonded to the surface before bonding to the polyethylene glycol spacer. 2. The device of claim 1 wherein the bioactive agent is a small molecule. 3. The device of claim 1 wherein the bioactive agent has antithrombotic activity. 4. The device of claim 3 wherein the bioactive agent is heparin. 5. The device of claim 1 wherein the surface is oxidized. 6. The device of claim 1 further comprising a bio-absorbable coating over the bioactive agent. 7. The device of claim 6 wherein the bio-absorbable coating comprises one or more polymers selected from the group consisting of poly(lactide-co-glycolide (PLGA); poly(dl-lactide) (DLPLA); poly(l-lactide) (LPLA); polyglycolide (PGA); poly(dioxanone) (PDO); poly(glycolide-co-trimethylene carbonate) (PGA-TMC); poly(l-lactide-co-glycolide) (PGA-LPLA); poly(dl-lactide-co-glycolide) (PGA-DLPLA); poly(l-lactide-co-dl-lactide) (LPLA-DLPLA); and poly(glycolide-co-trimethylene carbonate-co-dioxanone) (PDO-PGA-TMC). 8. The device of claim 6 wherein the bio-absorbable coating comprises at least one diffusible antistenotic drug. 9. The device of claim 1 wherein the substrate comprises one or more materials selected from the group consisting of stainless steel, cobalt chromium alloy, or alternative metallic alloys. 10. An implantable stent device comprising: a stent core having a surface;a layer of silane derivative comprising a terminal amine covalently bonded to the surface:a spacer layer comprising a hetero-bifunctional polyethelene glycol (PEG) derivative comprising a carboxyl group and an amine group wherein the spacer is between the silane derivative and a protein, the carboxyl group of the spacer being covalently bonded to the terminal amine of the silane derivative through a peptide bond; and a protein covalently bonded to the PEG amine group through a peptide bond; wherein the silane derivative is first bonded to the surface before bonding to the polyethylene glycol spacer. 11. The device of claim 10 wherein the surface is oxidized. 12. The device of claim 10 wherein the protein comprises antithrombogenic activity. 13. The device of claim 10 further comprising at least one coating layer over the protein, wherein the at least one coating layer is bio-absorbable. 14. The device of claim 13 wherein the at least one coating layer comprises one or more antistenotic drugs. 15. The device of claim 13 wherein the at least one coating layer comprises one or more immunosuppressive drugs. 16. The device of claim 15 wherein the one or more immunosuppressive drugs is selected from the group consisting of rapamycin (sirolimus), 40-O-(2-Hydroxyethyl)rapamycin (everolimus), 40-O-Benzyl-rapamycin, 40-O-(4′-Hydroxymethyl)benzyl-rapamycin, 40-O[4′-(1,2-Dihydroxyethyl)]benzyl-rapamycin, 40-O-Allyl-rapamycin, 40-O-[3′-(2,2-Dimethyl-1,3-dioxolan-4(S)-yl)-prop-2′-en-1′-yl]-rapamycin, (2′:E,4′S)-40-O-(4′,5′-Dihydroxypent-2′-en-1′-yl)-rapamycin, 40-O-(2-Hydroxy)ethoxycar-bonylmethyl-rapamycin, 40-O-(3-Hydroxy)propyl-rapamycin, 40-O-(6-Hydroxy)hexyl-rapamycin, 40-O-[2-(2-Hydroxy)ethoxy]ethyl-rapamycin, 40-O-[(3S)-2,2-Dimethyldioxolan-3-yl]methyl-rapamycin, 40-O-[(2S)-2,3-Dihydroxyprop-1-yl]-rapamycin, 40-O-(2-Acetoxy)ethyl-rapamycin, 40-O-(2-Nicotinoyloxy)ethyl-rapamycin, 40-O-[2-(N-Morpholino)acetoxy]ethyl-rapamycin, 40-O-(2-N-Imidazolylacetoxy)ethyl-rapamycin, 40-O-[2-(N-Methyl-N′-piperazinyl)acetoxy]ethyl-rapamycin, 39-O-Desmethyl-39,40-O,O-ethylene-rapamycin, (26R)-26-Dihydro-40-O-(2-hydroxy)ethyl-rapamycin, 28-O-Methyl-rapamycin, 40-O-(2-Nicotinamidoethyl)-rapamycin, 40-O-(2-Acetaminoethyl)-rapamycin, 40-O-(2-Tolylsulfonamidoethyl)-rapamycin, 40-O-(2-(N-Methyl-imidazo-2′-ylcarbethoxamido)ethyl)-rapamycin, 40-O-(2-Aminoethyl)-rapamycin, 40-O-(2-Ethoxycarbonylaminoethyl)-rapamycin, 40-O-[2-(4′,5′-Dicarboethoxy-1′,2′,3′-triazol-1′-yl)-ethyl]-rapamycin, 42-Epi-(tetrazolyl)rapamycin (tacrolimus), and 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin(temsirolimus). 17. The device of claim 13 wherein the at least one coating layer comprises at least one layer of bio-absorbable polymer material. 18. The device of claim 1 or 6 wherein the bioactive agent is selected from the group consisting of biopolymers, pharmaceutical agents, synthetic polymers, amino acids and small organic molecules. 19. The device of claim 1 or 6 wherein the device is selected from the group consisting of catheters, electrodes, stents, leads, pacemakers, cardioverter or defibrillator housings, artificial joints, screws, rods, ophthalmic implants, pins, bone plates, grafts, anastomotic devices, perivascular wraps, staples, shunts, dialysis grafts, colostomy bag attachment devices, ear drainage tubes, vertebral disks, suture anchors, hemostatic barriers, clamps, plates, clips, vascular implants, tissue scaffolds, dressings, bone substitutes, intraluminal devices and vascular supports. 20. A method of making a medical implant device, comprising: providing a device substrate having a surface;oxidizing the surface to produce an oxidized surface;reacting the oxidized surface with derivitized silane comprising a terminal amine to form a silane coating over the surface, the coating being covalently bonded to the surface;providing a bioactive agent; andcovalently bonding heterobifunctional polyethylene glycol comprising a carboxyl group and an amine group, the carboxyl group of the spacer being covalently bonded to the terminal amine of the derivitized silane surface through a peptide bond and the amine group of the polyethylene glycol covalently bonded to the bioactive agent to form a polyethylene glycol spacer between the derivitized silane and the bioactive agent. 21. The method of claim 20 wherein the bioactive agent has antithrombotic activity. 22. The method of claim 21 wherein the bioactive agent is heparin. 23. The method of claim 20 wherein the bioactive agent is a protein and wherein the covalently bonding occurs in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride to produce a peptide bond between the terminal amine of the derivitized silane and the heterobifunctional polyethylene glycol. 24. The method of claim 20 further comprising forming a bio-absorbable coating over the bioactive agent. 25. The method of claim 24 wherein the bio-absorbable coating comprises one or more polymers selected from the group consisting of poly(lactide-co-glycolide (PLGA); poly(dl-lactide) (DLPLA); poly(l-lactide) (LPLA); polyglycolide (PGA); poly(dioxanone) (PDO); poly(glycolide-co-trimethylene carbonate) (PGA-TMC); poly(l-lactide-co-glycolide) (PGA-LPLA); poly(dl-lactide-co-glycolide) (PGA-DLPLA); poly(l-lactide-co-dl-lactide) (LPLA-DLPLA); and poly(glycolide-co-trimethylene carbonate-co-dioxanone) (PDO-PGA-TMC). 26. The method of claim 24 wherein the bio-absorbable coating comprises at least one diffusible antistenotic drug. 27. A medical implant device comprising a stent; at least one silane derivative comprising a terminal amine covalently bonded to a surface of the stent; a bioactive agent; and a hetero-bifunctional polyethylene glycol spacer comprising a carboxyl group and an amine group between the silane derivative coating and the bioactive agent, the carboxyl group of the polyethylene glycol spacer being covalently bonded to the terminal amine of the silane derivative coating through a peptide bond and the amine group of the polyethylene glycol spacer being covalently bonded to the bioactive agent through a peptide bond; further comprising a plurality of layers that form a laminate coating on said stent; wherein at least one of said layers comprises a bioabsorbable polymer and at least one of said layers comprises a pharmaceutical agent selected from the group consisting of rapamycin, a prodrug, a derivative, a hydrate, an ester, and a salt thereof; wherein at least a portion of the pharmaceutical agent is in crystalline form; wherein the silane derivative coating is first bonded to the surface of the stent before bonding to the polyethylene glycol spacer. 28. The device of claim 27 wherein said laminate coating exhibits an X-ray spectrum showing the presence of said pharmaceutical agent in crystalline form. 29. The device of claim 27 wherein said laminate coating exhibits a Raman spectrum showing the presence of said pharmaceutical agent in crystalline form. 30. The device of claim 27 wherein said laminate coating exhibits a Differential Scanning calorimetry (DSC) curve showing the presence of said pharmaceutical agent in crystalline form. 31. The device of claim 27 wherein said laminate coating exhibits Wide Angle X-ray Scattering (WAXS) spectrum showing the presence of said pharmaceutical agent in crystalline form. 32. The device of claim 27 wherein said laminate coating exhibits a wide angle radiation scattering spectrum showing the presence of said pharmaceutical agent in crystalline form. 33. The device of claim 27 wherein said laminate coating exhibits an Infra Red (IR) spectrum showing the presence of said pharmaceutical agent in crystalline form. 34. The device of claim 27 wherein the laminate coating comprises at least two polymers wherein a first polymer is PLGA copolymer with a ratio of about 40:60 to about 60:40 and a second polymer is a PLGA copolymer with a ratio of about 70:30 to about 90:10.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (160)
Fenster, Aaron; Downey, Donal B., 3D ultrasound-guided intraoperative prostate brachytherapy.
Roby Mark S. (Killingworth CT) Bennett Steven L. (New Haven CT) Liu Cheng-Kung (Norwalk CT), Absorbable block copolymers and surgical articles fabricated therefrom.
Wang James C. (Norton) Roberts George R. (Arlington) Pederson ; Sr. Brian A. (So. Attleboro MA), Co-extruded medical balloons and catheter using such balloons.
Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
McKearn, John P.; Gordon, Gary; Cunningham, James J.; Gately, Stephen T.; Koki, Alane T.; Masferrer, Jaime L., Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent.
Liu Cheng-Kung (Norwalk CT) Jiang Ying (North Haven CT) Roby Mark S. (Killingworth CT) Bennett Steven L. (New Haven CT) Stevenson Richard P. (Colchester CT) Pietrangeli Jeffrey P. (Bridgeport CT), Composite bioabsorbable materials and surgical articles made therefrom.
Loscalzo, Joseph; Vita, Joseph A.; Loberg, Michael D.; Worcel, Manuel, Composition for treating vascular diseases characterized by nitric oxide insufficiency.
Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
Appel, Leah E.; Curatolo, William J.; Herbig, Scott M.; Nightingale, James A. S.; Thombre, Avinash G., Controlled release by extrusion of solid amorphous dispersions of drugs.
Chandrashekar Bhagya L. ; Zhou Mingxing ; Jarr Eileen M. ; Dunn Richard L., Controlled release liquid delivery compositions with low initial drug burst.
Merida A. D'Augustine ; James H. Liu ; Donald C. Harrison, Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections.
Burke,Sandra E.; Cromack,Keith R.; Mack,Matthew; Toner,John L., Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens.
Hoy Kenneth L. (St. Albans WV) Nielsen Kenneth A. (Charleston WV), Electrostatic liquid spray application of coating with supercritical fluids as diluents and spraying from an orifice.
Palmaz, Julio C.; Boyle, Christopher T.; Banas, Christopher E.; Wiseman, Roger W.; Marton, Denes, Endoluminal implantable devices and method of making same.
Francis Moussy ; Donald Kreutzer ; Diane Burgess ; Jeffrey Koberstein ; Fotios Papadimitrakopoulos ; Samuel Huang, Implant coating for control of tissue/implant interactions.
Yoon Seok-Joon,KRX ; Yeo Guw-Dong,KRX ; Kim You-Chan,KRX ; Seo Min-Hyo,KRX ; Pai Chaul-Min,KRX ; Jung Jong-Pyoung,KRX ; Lee Seung-Jin,KRX, Implantable bioresorbable membrane and method for the preparation thereof.
Canham, Leigh T; Barrett, Christopher P; Cox, Timothy I; Wright, Peter J; Bowditch, Andrew P, Implants for administering substances and methods of producing implants.
Mistrater Alan B. (Rochester NY) Pietrzykowski ; Jr. Stanley J. (Rochester NY) Klein Alfred O. (Rochester NY) Hendrix Loren E. (Webster NY) Petropoulos Mark C. (Ontario NY) Batt Gary A. (Fairport NY), Mandrel with flared, dish shaped disk and process for using mandrel.
Pletcher Timothy Allen ; Datta Pabitra ; Poux Christopher Just ; McCoy Randall Eugene, Method and apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate.
Burnham, Theodore A.; Cha, Sung W.; Walat, Robert H.; Kim, Roland Y.; Anderson, Jere R.; Stevenson, James F.; Suh, Nam P.; Pallaver, Matthew, Method and apparatus for microcellular polymer extrusion.
Lars Lidgren SE; Peter Bengtsson SE; Peter Sj{overscore (o)}vall SE; Bengt Wesslen SE, Method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof.
Luzzi Louis A. ; Needham Thomas E. ; Hossein Zia ; Dondeti Polireddy, Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa.
Anderson Jere R. (Newburyport MA) Jandris Louis J. (Georgetown MA) Barbere Michael D. (Dunstable MA) Murphy Richard T. (Dracut MA 4), Method of making a distensible dilatation balloon using a block copolymer.
McKearn, John P.; Gordon, Gary; Cunningham, James J.; Gately, Stephen T.; Koki, Alane T.; Masferrer, Jaime L., Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia.
DeYoung, James P.; Gross, Stephen M.; Wagner, Mark I.; McClain, James B., Methods and compositions for etch cleaning microelectronic substrates in carbon dioxide.
Roser, Bruce J.; Sanderson, Ian; Kampinga, Jaap; Colaco, Camilo, Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery.
D'Amato, Robert J.; Green, Shawn J.; Swartz, Jr., Glenn M.; Shah, Jamshed H.; Madsen, John, Methods and compositions for treating an ocular neovascular disease.
DeYoung, James P.; McClain, James B.; Gross, Stephen M.; Wagner, Mark I., Methods for transferring supercritical fluids in microelectronic and other industrial processes.
Cha Sung W. (Cambridge MA) Suh Nam P. (Sudbury MA) Baldwin Daniel F. (Medford MA) Park Chul B. (Cambridge MA), Microcellular thermoplastic foamed with supercritical fluid.
Tepper, Gary; Pestov, Dmitry; Levit, Natalia; Wnek, Gary, Molecular imprinting of small particles, and production of small particles from solid state reactants.
Beckert, Thomas; Petereit, Hans-Ulrich; Dressman, Jennifer; Rudolph, Markus, Multi-particulate form of medicament, comprising at least two differently coated forms of pellet.
Maxfield MacRae (Plainfield NJ) Christiani Brian R. (Maplewood NJ) Murthy Sanjeeva N. (Neshanic Station NJ) Tuller Harold (Long Valley NJ), Nanocomposites of gamma phase polymers containing inorganic particulate material.
Cecchi, Roberto; Croci, Tiziano; Guzzi, Umberto; Marsault, Eric, Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same.
Raeder-Devens, Jennifer E.; Shelso, Susan I.; Hemerick, James F.; Schneider, Eric M.; Getty, Heather L.; Borgmann, Doreen M.; Sisombath, Kakao; Helgerson, Jeffrey A., Prosthesis deployment device with translucent distal end.
Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Osborne Thomas A. ; Kozma Thomas G. ; Roberts Joseph W. ; Voorhees ; III William D., Silver implantable medical device.
Lafont Antoine,FRX ; Vert Michel R.,FRX ; Cornhill Fredrick ; Li Suming,FRX ; Garreau Henri L.,FRX, Stent having a programmed pattern of in vivo degradation.
Setterstrom Jean A. ; Van Hamont John E. ; Reid Robert H. ; Jacob Elliot ; Jeyanthi Ramasubbu ; Boedeker Edgar C. ; McQueen Charles E. ; Jarboe Daniel L. ; Cassels Frederick ; Brown William ; Thies C, Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix.
Tsukashima Ross (San Diego CA) Jordan Matthew (Los Angeles CA) Jung Gordon (San Diego CA), Tri-fold balloon for dilatation catheter and related method.
Rodrigues Jose,FRX ; Belmain Daniel,FRX ; Barlet Thierry,FRX, Triboelectric projector, installation for projecting coating product and process for controlling such a projector.
Fulton, John L.; Deverman, George S.; Matson, Dean W.; Yonker, Clement R.; Taylor, C. Douglas; McClain, James B.; Crowley, Joseph M., System and method for enhanced electrostatic deposition and surface coatings.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.